📰 Immunexpress Inc News

Immunexpress Inc News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Immunexpress Inc. Real-time updates on events, politics, business and more.

Sepsis Diagnostics Market to Double by 2032, Reaching USD 1.8 Billion | Marketresearch.biz

April 12, 2024

Marketresearch.biz reports that the Sepsis Diagnostics Market size is expected to be worth around USD 1.8 Bn by 2032 from USD 0.9 Bn in 2022, growing at a CAGR of 7.8% during the forecast period from 2023 to 2032.Overview of the Sepsis Diagnostics MarketThe Sepsis Diagnostics Market focuses on technologies and tests...

New York United States Saudi Arabia United Kingdom Asia Pacific Lawrence John

Source: pharmiweb.com

SeptiCyte RAPID® By Immunexpress Receives Regulatory Clearance from Australian Therapeutic Goods Administration (TGA)

January 16, 2024

Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced that SeptiCyte® RAPID has received regulatory clearance by the Australian Therapeutic Goods Administration (TGA). The clearance of the company's flagship medical device by the regulatory body allows for the sale, use and further commercial testing of SeptiCyte RAPID throughout Australia to differentiate infection-positive (sepsis) from infection-negative s...

Biocarti Idylla Biocartis Idylla Adam Irwin Scott Stachowiak Richard Brandon Maddie Stabinski

Source: yahoo.com

Sepsis Diagnostics Market to Surpass US$ 1,624.6 Million by 2030

November 21, 2023

/PRNewswire/ -- According to Coherent Market Insights, Global Sepsis Diagnostics Market size was valued at US$ 841.4 Million in 2023 and is expected to surpass...

United Kingdom North Carolina United States France General Nordrhein Westfalen South Korea

Source: prnewswire.com

Data Presentation at Association for Molecular Pathology 2023 Validates Performance of SeptiCyte® RAPID in Immunocompromised Patients and Patients on Immunosuppressive Therapy

November 17, 2023

/PRNewswire/ -- Immunexpress, Pty Ltd., a molecular diagnostics company focused on rapid diagnosis and improved outcomes for suspected sepsis patients, today...

Noord Holland United States Rush University Rush University Medical Center Salt Lake City Biocartis Idylla

Source: prnewswire.com

CHEST 2023 Poster Demonstrates the Utility of SeptiCyte® RAPID in Antibiotic Administration and Sepsis Bundle Compliance

October 2, 2023

/PRNewswire/ -- Immunexpress, Pty Ltd., a molecular diagnostics company focused on rapid diagnosis and improved outcomes for suspected sepsis patients, today...

United States Moses Cone North Carolina Immunexpres Septicyte Maddie Stabinski Rakesh Alva

Source: prnewswire.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

New Publication Further Validates SeptiCyte® RAPID for Disease Severity Assessment and Triaging in COVID-19 Patients with Extensive Lung Injury

March 2, 2023

/PRNewswire/ -- Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, announced today the...

Rollie Carlson Marc Vasse Maddie Stabinski Scott Stachowiak Biocartis Idylla Biocarti Idylla

Source: prnewswire.com

Research and Markets: Europe Sepsis Diagnostics Market Report 2022: Rise in Funding and Support for Sepsis Diagnostics Research Presents Opportunities

October 18, 2022

The "Europe Sepsis Diagnostics Market Forecast to 2028 COVID-19 Impact and Regional Analysis By Product, Technology, Method, Test Type, Pathogen, and End User" report has been added to ResearchAndMarkets.com's

United Kingdom Kostenloser Wertpapierhandel Danaher Beckman Coulter F Hoffman Laroche Laura Wood Biosystems Inc

Source: finanznachrichten.de

Immunexpress Announces the Launch of New SeptiCyte RAPID® CE-IVD EDTA Blood Compatible Cartridges

August 23, 2022

/PRNewswire/ -- Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, announced today the launch...

Rollie Carlson Immunexpres Septicyte Biocartis Idylla Biocarti Idylla Kathleen Silverman Pty Ltd

Source: prnewswire.com

Sepsis Diagnostics Market by Technology, Product, Test Type, Pathogen, End-user and Region

March 23, 2022

/PRNewswire/ -- The "Global Sepsis Diagnostics Market by Technology (Microbiology, PCR, Sequencing, Biomarkers), Product (Reagents, Assay, Instruments,...

United States Siemens Healthineers Laura Wood Other Companies Pathology Lab Sysmex Corporation

Source: prnewswire.com